# LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients

> **NCT03140111** · NA · UNKNOWN · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 12 (estimated)

## Conditions studied

- Dry Eye Syndromes
- Primary Sjögren Syndrome

## Interventions

- **DEVICE:** LAMELLEYE
- **DEVICE:** OPTIVE FUSION

## Key facts

- **NCT ID:** NCT03140111
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-16
- **Primary completion:** 2018-03-30
- **Final completion:** 2018-03-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2017-09-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03140111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03140111, "LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03140111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*